{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-065744","form_type":"8-K","ticker":"GRML","cik":"0001907223","company_name":"Greenland Mines Ltd","filed_at":"2025-07-18T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.569084+00:00","generated_at":"2026-05-18T05:50:16.189621+00:00","sec_items":["3.01","7.01","9.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Klotho regains Nasdaq bid price and equity compliance; phase-down to Capital Market approved","bullets":["Regained compliance with Nasdaq minimum $1.00 bid price and $2.5M stockholders' equity requirements.","Nasdaq approved phase-down of listing from Global Market to Capital Market; shares trade as KLTO and KLTOW.","One-year monitoring period for equity compliance; non-compliance could lead to delisting without cure period."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-065744","json":"https://secwatch.observer/filing/0001213900-25-065744.json","markdown":"https://secwatch.observer/filing/0001213900-25-065744.md","text":"https://secwatch.observer/filing/0001213900-25-065744.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1907223/000121390025065744/0001213900-25-065744-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1907223/000121390025065744/ea0249595-8k_klotho.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T05:50:16.189621+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"67863b714f72da22981a9cb6df5ce72ce5ee33da","claim":"Greenland Mines Ltd received a nasdaq compliance regained notice regarding stockholders equity (rules 5550(b)(1)).","evidence_excerpt":"July 14, 2025, Klotho Neurosciences, Inc. (the “Company”), received a letter from the Staff of The Nasdaq Stock Market LLC (“Nasdaq”) confirming that the Company has regained compliance with the minimum $1.00 bid price under NASDAQ Listing Rule 5550(a)(2), and the minimum stockholders’ equity threshold of $2.5 million under Listing Rule 5550(b)(1). In addition, on July 14. 2025, Nasdaq approved the Company’s application to “phase down” the listing of its common stock and warrants from the Nasdaq Global Market to the Nasdaq Capital Market. The Company’s common stock will continue to trade under","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1907223/000121390025065744/0001213900-25-065744-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"compliance regained"},{"label":"Deficiency","value":"stockholders equity"},{"label":"Rules","value":"5550(b)(1)"}],"fact_type":"exchange_compliance_notice"},{"claim_id":"d51df4ce2f3deae6cf1c5790a98ca98507b3fae5","claim":"Greenland Mines Ltd received a nasdaq compliance regained notice regarding minimum bid price (rules 5550(a)(2)).","evidence_excerpt":"July 14, 2025, Klotho Neurosciences, Inc. (the “Company”), received a letter from the Staff of The Nasdaq Stock Market LLC (“Nasdaq”) confirming that the Company has regained compliance with the minimum $1.00 bid price under NASDAQ Listing Rule 5550(a)(2), and the minimum stockholders’ equity threshold of $2.5 million under Listing Rule 5550(b)(1). In addition, on July 14. 2025, Nasdaq approved the Company’s application to “phase down” the listing of its common stock and warrants from the Nasdaq Global Market to the Nasdaq Capital Market. The Company’s common stock will continue to trade under","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1907223/000121390025065744/0001213900-25-065744-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"compliance regained"},{"label":"Deficiency","value":"minimum bid price"},{"label":"Rules","value":"5550(a)(2)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}